Silicon Laboratories Inc. (NASDAQ:SLAB) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Silicon Laboratories Inc. (NASDAQ:SLAB) have been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are covering the company, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $136.20.

SLAB has been the topic of several research analyst reports. Barclays raised their price objective on Silicon Laboratories from $75.00 to $120.00 and gave the company an “equal weight” rating in a research note on Friday, January 17th. Needham & Company LLC restated a “buy” rating and issued a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, March 12th. StockNews.com lowered shares of Silicon Laboratories from a “hold” rating to a “sell” rating in a report on Thursday, March 27th. Benchmark reissued a “buy” rating and issued a $160.00 price objective on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Finally, Stifel Nicolaus boosted their target price on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Monday, January 6th.

Silicon Laboratories Stock Down 7.1 %

SLAB stock opened at $92.08 on Tuesday. Silicon Laboratories has a 52 week low of $89.05 and a 52 week high of $160.00. The business has a 50-day simple moving average of $133.58 and a 200 day simple moving average of $123.56. The company has a market cap of $2.99 billion, a PE ratio of -15.50 and a beta of 1.33.

Silicon Laboratories (NASDAQ:SLAB) last issued its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). The company had revenue of $166.25 million during the quarter, compared to analysts’ expectations of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business’s revenue for the quarter was up 91.4% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.19) EPS. On average, analysts anticipate that Silicon Laboratories will post -0.97 EPS for the current fiscal year.

Insider Transactions at Silicon Laboratories

In related news, Director William G. Bock sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the sale, the director now directly owns 32,115 shares in the company, valued at $4,520,828.55. This represents a 5.86 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the transaction, the director now owns 400,567 shares of the company’s stock, valued at approximately $59,684,483. The trade was a 0.59 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,360 shares of company stock worth $782,610. Company insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On Silicon Laboratories

Several hedge funds and other institutional investors have recently bought and sold shares of SLAB. FMR LLC raised its position in shares of Silicon Laboratories by 0.5% in the 4th quarter. FMR LLC now owns 4,867,203 shares of the semiconductor company’s stock worth $604,604,000 after acquiring an additional 23,833 shares in the last quarter. Vanguard Group Inc. grew its stake in Silicon Laboratories by 1.9% during the fourth quarter. Vanguard Group Inc. now owns 3,959,580 shares of the semiconductor company’s stock worth $491,859,000 after purchasing an additional 71,942 shares during the period. Capital Research Global Investors increased its holdings in Silicon Laboratories by 23.3% in the fourth quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company’s stock worth $264,827,000 after purchasing an additional 403,010 shares in the last quarter. Wellington Management Group LLP lifted its stake in Silicon Laboratories by 28.3% in the third quarter. Wellington Management Group LLP now owns 888,382 shares of the semiconductor company’s stock valued at $102,670,000 after buying an additional 195,997 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in shares of Silicon Laboratories by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 781,049 shares of the semiconductor company’s stock worth $90,282,000 after buying an additional 15,728 shares in the last quarter.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.